Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : View from the Center and Left -- Ignore unavailable to you. Want to Upgrade?

To: T L Comiskey who wrote (191794)	6/16/2012 6:18:21 PM
From: epicure	Respond to of 543695

You really have to wonder about these situations. I don't mind people eating GMO if they want to. People should have the choice- assuming the stuff isn't deadly for everyone. But consumers should have the choice- so they can buy something else if they want to. Why are these big companies so afraid of consumer choice?

To: T L Comiskey who wrote (191794)	6/17/2012 9:28:47 AM
From: Bread Upon The Water	Read Replies (3) \| Respond to of 543695

Europeans in general, and European Farm groups in particular who have a lot to lose economically if GMO products are available in Europe, are biased against this product. They lobby their politicians constantly to prevent importation of this product and European environmental green groups have a cottage industry going in propagandizing GMO products out of European existence. Additionally, all the evidence presented to these courts was unscientific opinion. Now I do not know anything about GMO corn scientifically, but my point is that I doubt a fair trail could have been had in this instance and that there were politics involved in the case. As far as not disclosing ingredients of GMO products there are huge sums of money tied up in these patents and third world countries which are not signatories to the International Patent treaties wouldn't hesitate, IMHO, to use this information to their benefit much as they have done with pharmaceutical products. So that is the other side of this "story".